K. Kameyama et al., INHIBITORY EFFECT OF MAGNESIUM L-ASCORBYL-2-PHOSPHATE (VC-PMG) ON MELANOGENESIS IN-VITRO AND IN-VIVO, Journal of the American Academy of Dermatology, 34(1), 1996, pp. 29-33
Background: An inhibitory effect of ascorbic acid (AsA) on melanogenes
is has been described. However, AsA is quickly oxidized and decomposed
in aqueous solution and thus is not generally useful as a depigmentin
g agent. Objective: Our purpose was to examine the effect on pigmentat
ion of magnesium-L-ascorbyl-2-phosphate (VC-PMG), a stable derivative
of AsA. Methods: Percutaneous absorption of VC-PMG was examined in der
matomed human skin, and its effect on melanin production by mammalian
tyrosinase and human melanoma cells in culture was also measured. A 10
% VC-PMG cream was applied to the patients. Results: VC-PMG suppressed
melanin formation by tyrosinase and melanoma cells. In situ experimen
ts demonstrated that VC-PMG cream was absorbed into the epidermis and
that 1.6% remained 48 hours after application. The lightening effect w
as significant in 19 of 34 patients with chloasma or senile freckles a
nd in 3 of 25 patients with normal skin. Conclusion: VC-PMG is effecti
ve in reducing skin hyperpigmentation in some patients.